[The pentoxifylline, a corticosteroid sparing in the treatment of sarcoidosis: A case report]

Rev Pneumol Clin. 2018 Feb;74(1):48-51. doi: 10.1016/j.pneumo.2017.08.014. Epub 2017 Nov 6.
[Article in French]

Abstract

Introduction: The pentoxifylline seems to have some effects on immune cells by inhibiting tumor necrosis factor alpha (TNFα). Its role as a sparing corticosteroids in the treatment of sarcoidosis remains to be defined.

Clinical case: We present the case of a patient with sarcoidosis corticodependent despite the use of azathioprine. It was finally improved clinically, functionally and by a thoracic computed tomography with addition of pentoxifylline.

Conclusion: When the tolerance of the pentoxifylline is good and there is not a bleeding risk, the benefit-risk in the long term might be interesting in some patients with sarcoidosis corticodependent.

Keywords: Sarcoidose; Sarcoidosis; Steroid sparing; Épargneur de corticoïdes.

Publication types

  • Case Reports

MeSH terms

  • Azathioprine / therapeutic use
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Middle Aged
  • Pentoxifylline / therapeutic use*
  • Phosphodiesterase Inhibitors / therapeutic use*
  • Sarcoidosis / drug therapy*
  • Tomography, X-Ray Computed
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Glucocorticoids
  • Immunosuppressive Agents
  • Phosphodiesterase Inhibitors
  • Tumor Necrosis Factor-alpha
  • Azathioprine
  • Pentoxifylline